Kevin Outterson

Boston University School of Law

Associate Professor

765 Commonwealth Avenue

Boston, MA 02215

United States

SCHOLARLY PAPERS

54

DOWNLOADS
Rank 2,718

SSRN RANKINGS

Top 2,718

in Total Papers Downloads

10,773

CITATIONS
Rank 12,919

SSRN RANKINGS

Top 12,919

in Total Papers Citations

30

Scholarly Papers (54)

1.

Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets

Yale Journal of Health Policy, Law, and Ethics, December 2004
Number of pages: 99 Posted: 25 Jul 2004
Kevin Outterson
Boston University School of Law
Downloads 1,007 (13,464)
Citation 2

Abstract:

WTO, TRIPS, Doha, Essential Medicines, innovation, access, pharmaceutical, differential pricing, price discrimination, diversion

2.

Counterfeit Drugs: The Good, the Bad and the Ugly

Albany Law Journal of Science and Technology, Vol. 15, 2006
Number of pages: 15 Posted: 30 Aug 2006
Kevin Outterson and Ryan Smith
Boston University School of Law and West Virginia University - College of Law
Downloads 670 (28,396)

Abstract:

counterfeit, drug, pharmaceutical, intellectual property, trade

3.

The Ethics of Poverty Tourism

Boston Univ. School of Law Working Paper No. 09-29
Number of pages: 23 Posted: 03 Jun 2009 Last Revised: 15 Nov 2010
Kevin Outterson and Evan Selinger
Boston University School of Law and Rochester Institute of Technology - Department of Philosophy
Downloads 616 (28,530)
Citation 2

Abstract:

Poverty tours, ethical tourism, justice tourism, alternative globalization, development ethics

4.

Plunging Into Endless Difficulties: Medicaid and Coercion in National Federation of Independent Businesses v. Sebelius

93 B.U.L. Rev. 1 (2013), Boston Univ. School of Law, Public Law Research Paper No. 12-40
Number of pages: 89 Posted: 13 Aug 2012 Last Revised: 02 Oct 2015
University of Kentucky College of Law, University of Georgia School of Law and Boston University School of Law
Downloads 515 (37,537)

Abstract:

coercion, Tenth Amendment, Medicaid, spending power

5.

Should Access to Medicines and TRIPS Flexibilities Be Limited to Specific Diseases?

American Journal of Law and Medicine, Vol. 34, 2008, Boston Univ. School of Law Working Paper No. 08-06
Number of pages: 22 Posted: 05 Feb 2008 Last Revised: 17 Feb 2014
Kevin Outterson
Boston University School of Law
Downloads 482 (42,126)
Citation 1

Abstract:

The WHO IGWG, the WHO CIPIH, World Health Organization's Commission on Innovation, Intellectual Property and Public Health, Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), TRIPS flexibilities

6.

Patent Buy-Outs for Global Disease Innovations for Low- and Middle-Income Countries

American Journal of Law and Medicine, Vol. 32, 2006
Number of pages: 16 Posted: 03 Jan 2006
Kevin Outterson
Boston University School of Law
Downloads 468 (43,434)
Citation 2

Abstract:

patent, global disease, innovation, orphan disease, intellectual property

7.

Poverty Tourism and the Problem of Consent

Journal of Global Ethics, Vol. 7, No. 3, pp. 337-348, Boston Univ. School of Law, Public Law Research Paper No. 11-22
Number of pages: 13 Posted: 01 Jan 2011 Last Revised: 01 Sep 2014
Kyle Whyte, Evan Selinger and Kevin Outterson
Michigan State University - Department of Philosophy, Rochester Institute of Technology - Department of Philosophy and Boston University School of Law
Downloads 408 (46,405)

Abstract:

Poverty tourism, poorism, exploitation, tourism ethics, fair trade

8.

Affirmative Action as Reparations for Slavery and Legal Discrimination: Amicus Brief in Support of Respondents

Number of pages: 34 Posted: 03 Jun 2003
Kevin Outterson
Boston University School of Law
Downloads 359 (46,893)
Citation 1

Abstract:

reparations, equal protection, affirmative action, racial preferences, fourteenth amendment

9.

Import Safety Rules Should Not Hinder Legitimate Generic Drug Markets: The Anti-Counterfeiting Trade Agreement (ACTA)

IMPORT SAFETY: REGULATORY GOVERNANCE IN THE GLOBAL ECONOMY, Cary Coglianese, Adam Finkel, David Zaring, eds., The University of Pennsylvania Press, 2009, Boston Univ. School of Law Working Paper No. 9-25
Number of pages: 30 Posted: 25 May 2009 Last Revised: 30 Jul 2014
Kevin Outterson
Boston University School of Law
Downloads 345 (67,568)

Abstract:

counterfeit, drug, pharmaceutical, Anti-Counterfeit Trade Agreement, ACTA, IMPACT

10.

The Vanishing Public Domain: Antibiotic Resistance, Pharmaceutical Innovation and Global Public Health

University of Pittsburgh Law Review, Vol. 67, pp. 67-123, 2005
Number of pages: 56 Posted: 03 Jan 2006
Kevin Outterson
Boston University School of Law
Downloads 331 (65,842)
Citation 4

Abstract:

antibiotic, resistance, pharmaceutical, innovation, intellectual property

11.

The Legal Ecology of Resistance: The Role of Antibiotic Resistance in Pharmaceutical Innovation

Cardozo Law Review, Forthcoming, Boston Univ. School of Law Working Paper No. 09-48
Number of pages: 67 Posted: 22 Oct 2009 Last Revised: 19 Feb 2014
Kevin Outterson
Boston University School of Law
Downloads 271 (81,433)
Citation 3

Abstract:

antibiotic, antimicrobial, resistance, pharmaceutical, innovation, intellectual property, patent, reimbursement, MRSA, public health

12.

Global Pharmaceutical Markets

COMPANION TO BIOETHICS (SECOND EDITION), pp. 417-429, Helga Kuhse and Peter Singer, eds., Wiley Intescience, Blackwell Companions to Philosophy, January 2010, Boston Univ. School of Law Working Paper No. 10-05
Number of pages: 30 Posted: 06 Mar 2010
Kevin Outterson and Donald W. Light
Boston University School of Law and Rowan University School of Osteopathic Medicine
Downloads 264 (84,373)

Abstract:

Patent, Intellectual Property, Duty of Rescue, Pharmaceutical, Drug, Access to Medicine

13.

Free Trade Against Free Riders?

Pharma Pricing & Reimbursement, Vol. 9, No. 9, pp. 254-255, September 2004
Number of pages: 2 Posted: 08 Nov 2004
Kevin Outterson
Boston University School of Law
Downloads 244 (99,814)
Citation 3

Abstract:

Free rider, pharmaceutical, USTR, trade agreements, R&D

14.

Fair Followers: Expanding Access to Generic Pharmaceuticals for Low- and Middle-Income Populations

THE POWER OF PILLS, Jillian Clare Cohen, Patricia Illingworth, Udo Schuklenk, eds., University of Michigan Press, 2005
Number of pages: 16 Posted: 17 Jun 2006
Kevin Outterson
Boston University School of Law
Downloads 236 (98,583)
Citation 1

Abstract:

pharmaceutical, pricing, patents, innovation, nonrivalrous, access, developing countries, low income countries

15.

Improving Antibiotic Markets for Long Term Sustainability

Yale Journal of Health Policy, Law & Ethics, Vol. 11, Winter 2011, Boston Univ. School of Law Working Paper (Law & Economics) No. 10-42, Boston Univ. School of Law Working Paper (Public Law & Legal Theory) No. 10-42
Number of pages: 71 Posted: 07 Dec 2010 Last Revised: 16 Apr 2013
Aaron S. Kesselheim and Kevin Outterson
Brigham and Women's Hospital/Harvard Medical School and Boston University School of Law
Downloads 218 (95,774)

Abstract:

antibiotic, resistance, intellectual property, patent, conservation, prize

16.

Will Longer Antimicrobial Patents Improve Global Public Health?

Lancet Infectious Diseases, Vol. 7, pp. 559-566, 2007 , Boston Univ. School of Law Working Paper No. 07-22
Number of pages: 9 Posted: 28 Aug 2007
Kevin Outterson, Julie Balch Samora and Karen Keller-Cuda
Boston University School of Law, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 178 (132,022)
Citation 2

Abstract:

intellectual property, antimicrobial resistance, wildcard patents, patent extensions

17.

Tragedy & Remedy: Reparations for Disparities in Black Health

DePaul Journal of Health Care Law, Vol. 9, No. 1, pp. 735-792, 2005, West Virginia University College of Law Working Paper
Number of pages: 58 Posted: 12 Oct 2005
Kevin Outterson
Boston University School of Law
Downloads 175 (121,276)

Abstract:

Disparities, health, race, reparations, Black

18.

Agony in the Antipodes: The Generic Drug Provisions of the Australia-U.S. Free Trade Agreement

Journal of Generic Medicines, Vol. 2, No. 4, pp. 316-326, July 2005
Number of pages: 14 Posted: 24 Aug 2005
Kevin Outterson
Boston University School of Law
Downloads 174 (139,621)
Citation 3

Abstract:

Australia, United States, free trade agreement, AUSFTA, generic, pharmaceutical, Hatch-Waxman, transparency

19.

William H. Sorrell, Attorney General of Vermont, et al. v. IMS Health Inc., et al. - Amicus Brief in Support of Petitioners

Number of pages: 55 Posted: 01 Mar 2011 Last Revised: 11 Mar 2014
Boston University School of Law, Indiana University - Robert H. McKinney School of Law, University of Arizona - James E. Rogers College of Law and University of Maryland Francis King Carey School of Law
Downloads 169 (137,542)

Abstract:

first amendment, commercial speech, privacy, confidentiality, data mining, HIPAA

20.

Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis

RESEARCH HANDBOOK ON INTELLECTUAL PROPERTY LAW AND THE WTO, Carlos Correa, ed., Edward Elgar, 2009, Boston Univ. School of Law Working Paper No. 09-26
Number of pages: 22 Posted: 20 May 2009
Kevin Outterson
Boston University School of Law
Downloads 165 (138,211)
Citation 1

Abstract:

compulsory license, TRIPS, pharmaceuticals, USTR, disease

21.

Physicians’ Brief in the Second Circuit Data Mining Cases (IMS V. Sorrell) on Behalf of Amici Curiae New England Journal of Medicine, Vermont Medical Society, Massachusetts Medical Society, New Hampshire Medical Society, National Physicians Alliance, and American Medical Students Association

Boston Univ. School of Law Working Paper No. 09-44, Harvard Public Law Working Paper No. 09-55
Number of pages: 43 Posted: 19 Sep 2009 Last Revised: 28 Feb 2014
Boston University School of Law, University of Arizona - James E. Rogers College of Law and Indiana University - Robert H. McKinney School of Law
Downloads 164 (143,986)

Abstract:

public law, constitutional law, first amendment, health law, electronic health records, privacy, data mining, pharmaceuticals, marketing

22.

Resolving Dysfunctional Pharmaceutical Arbitrage and Counterfeiting through the Proposed Hubbard-Love R&D Treaty

Number of pages: 10 Posted: 18 Nov 2004
Kevin Outterson
Boston University School of Law
Downloads 164 (143,230)

Abstract:

IP, IPR, intellectual property, parallel trade, pharmaceutical arbitrage, counterfeit, pharmaceutical, drug, essential medicines, access, R&D treaty, innovation, diversion

23.

Access to Global Disease Innovation

Number of pages: 7 Posted: 16 Nov 2006
Kevin Outterson
Boston University School of Law
Downloads 154 (150,988)

Abstract:

intellectual property, IP, access, innovation, essential medicines, patent, pharmaceutical

24.

Agents Without Principals: Regulating the Duty of Loyalty for Nonprofit Corporations Through the Intermediate Sanctions Tax Regulations

Pepperdine Journal of Business, Entrepreneurship & The Law XXX, 2012 (Forthcoming), Boston Univ. School of Law, Law and Economics Research Paper No. 12-28, Boston Univ. School of Law, Public Law Research Paper No. 12-28
Number of pages: 30 Posted: 02 Jun 2012
Carly B. Eisenberg and Kevin Outterson
Nixon Peabody LLP and Boston University School of Law
Downloads 151 (150,184)

Abstract:

tax exempt, fiduciary duty

25.

Approval and Withdrawal of New Antibiotics and Other Antiinfectives in the U.S., 1980-2009

Journal of Law, Medicine and Ethics, p. 688, Fall 2013, Boston Univ. School of Law, Law and Economics Research Paper No. 13-47
Number of pages: 10 Posted: 18 Sep 2013 Last Revised: 08 Aug 2015
Boston University School of Law, George Washington University, Director International Center for Pharmaceutical Economics and Policy, University of Massachusetts and Brigham and Women's Hospital/Harvard Medical School
Downloads 139 (133,416)

Abstract:

antibiotics, innovation, resistance

26.

Combating Antibiotic Resistance Through the Health Impact Fund

Boston Univ. School of Law, Law and Economics Research Paper No. 11-30
Number of pages: 36 Posted: 19 Jun 2011 Last Revised: 01 Nov 2011
Kevin Outterson, Thomas Pogge and Aidan Hollis
Boston University School of Law, Yale Philosophy Department and University of Calgary - Department of Economics
Downloads 134 (150,988)

Abstract:

health impact, antibiotic, resistance, pay-for-performance

27.

Poverty Tourism, Justice and Policy

Public Integrity, 2011 , Boston Univ. School of Law, Public Law Research Paper No. 11-21, Boston Univ. School of Law, Law & Economics Research Paper No. 11-21
Number of pages: 22 Posted: 24 May 2011
Evan Selinger, Kevin Outterson and Kyle Whyte
Rochester Institute of Technology - Department of Philosophy, Boston University School of Law and Michigan State University - Department of Philosophy
Downloads 120 (161,324)

Abstract:

Alternative tourism, distributive justice, recognition justice, procedural justice, poorism

28.

The End of Reparations Talk? - Reparations in an Obama World

Kansas Law Review, Vol. 57, No. 4, 2009, Boston Univ. School of Law Working Paper No. 09-16
Number of pages: 15 Posted: 20 Feb 2009 Last Revised: 16 Apr 2009
Kevin Outterson
Boston University School of Law
Downloads 90 (221,559)

Abstract:

reparations, Obama, health disparities, disparities, racial disparities, slavery, segregation

29.

U.S. Senate Testimony on the Dept. of Commerce OECD Drug Pricing Report

US SENATE HEALTH, EDUCATION, LABOR & PENSION COMMITTEE HEARINGS, February 2005
Number of pages: 14 Posted: 25 Apr 2005
Kevin Outterson
Boston University School of Law
Downloads 84 (234,265)

Abstract:

OECD, drug, pharmaceutical, pricing, reimbursement, free riding, differential pricing

30.

New Business Models for Sustainable Antibiotics

Centre on Global health Security Working Group Papers, Chatham House (The Royal Institute of International Affairs), Working Groups on Antimicrobial Resistance, Paper 1, February, 2014 , Boston Univ. School of Law, Public Law Research Paper No. 14-10, Boston Univ. School of Law, Law and Economics Research Paper No. 14-10
Number of pages: 34 Posted: 20 Feb 2014
Kevin Outterson
Boston University School of Law
Downloads 80 (142,468)

Abstract:

antibiotics, infection control, antibiotic conservation, antibiotic business models, antibiotic effectiveness, public health, market incentives, inadequate market incentives, sustainable antibiotics

31.

Death from the Public Domain?

Texas Law Review (See Also Online Supplement), Vol. 87, pp. 45-55, 2010, Boston University Law & Economics Research Paper No. 10-45, Boston University Public Law & Legal Theory Research Paper No. 10-45
Number of pages: 12 Posted: 16 Dec 2010
Kevin Outterson
Boston University School of Law
Downloads 78 (248,289)

Abstract:

Antibiotic, Antimicrobial, Resistance, Pharmaceutical, Innovation, Intellectual Property, Abbreviated New Drug Application (ANDA) Process, Public Domain

32.

After the Deluge: Health Reform Without an Individual Mandate

Kaiser Health News, February 2011, Boston Univ. School of Law, Public Law Research Paper No.p 11-20
Number of pages: 2 Posted: 21 Jun 2011 Last Revised: 04 Jul 2011
Austin Frakt and Kevin Outterson
Government of the United States of America - Department of Veterans Affairs (VA) and Boston University School of Law
Downloads 71 (261,751)

Abstract:

Affordable Health Care Act, Medicare, individual state mandate, free-riding on the insurance market

33.

US Senate Health, Education, Labor, & Pensions Committee Hearing on Drug Importation - Response to Dean Arnold

Number of pages: 4 Posted: 01 May 2005
Kevin Outterson
Boston University School of Law
Downloads 63 (278,775)

Abstract:

Drug importation, Dorgan-Snowe, reimportation, FDA, constitution, international law

34.

Brief of Amici Curiae Health Law & Policy Scholars and Prescriptions Policy Choices in Support of Respondents on the Constitutional Validity of the Medicaid Expansion in State of Florida v. Department of Health and Human Services

Boston Univ. School of Law, Public Law Research Paper No. 12-27, Boston Univ. School of Law, Law and Economics Research Paper No. 12-27
Number of pages: 61 Posted: 30 May 2012
Boston University School of Law, Mitchell Hamline School of Law, University of Kentucky College of Law, University of Georgia School of Law, George Washington University - Department of Health Policy and affiliation not provided to SSRN
Downloads 60 (274,377)

Abstract:

Medicaid, Section 2001(a)(1)(C) of the Patient Protection and Affordable Care Act, The Patient Protection and Affordable Care Act, health care coverage, South Dakota v. Dole (483 U.S. 203 (1987))

An International Legal Framework to Address Antimicrobial Resistance

Bulletin of the World Health Organization 2015;93:66, Boston Univ. School of Law, Public Law Research Paper No. 15-33, Boston Univ. School of Law, Law and Economics Research Paper No. 15-33
Number of pages: 2 Posted: 11 Aug 2015 Last Revised: 25 Mar 2016
University of Ottawa - Common Law Section, Boston University School of Law, Norwegian Knowledge Center for the Health Services, ReAct - Action on Antibiotic Resistance, Centre on Global Health Security - Chatham House, Dag Hammarskjöld Foundation, Karolinska Institutet and ReAct - Action on Antibiotic Resistance
Downloads 42 (355,593)

Abstract:

antiobiotic resistance, collection action, innovation, delinkage

An International Legal Framework to Address Antimicrobial Resistance

Bulletin of the World Health Organization, 2015, 93:66
Number of pages: 1 Posted: 05 Feb 2016
University of Ottawa - Common Law Section, Boston University School of Law, Norwegian Knowledge Center for the Health Services, ReAct - Action on Antibiotic Resistance, Centre on Global Health Security - Chatham House, Yale University, Law School, Students, Dag Hammarskjöld Foundation, Karolinska Institutet and ReAct - Action on Antibiotic Resistance
Downloads 16 (479,055)

Abstract:

antimicrobial, resistance, global, health, threat, access, conservation, innovation, coordnation, mechanism

36.
Downloads 54 (290,255)

Abstract:

37.

Deductions for Drug Ads? The Constitution Does Not Require Congress to Subsidize Direct-to-Consumer Prescription Drug Advertisements

Santa Clara Law Review, Vol. 52, p. 453, 2012, Boston Univ. School of Law, Public Law Research Paper No. 12-11
Number of pages: 43 Posted: 27 Feb 2012
Shoshana Speiser and Kevin Outterson
affiliation not provided to SSRN and Boston University School of Law
Downloads 52 (276,568)

Abstract:

First Amendment, Commercial Speech, Direct to Consumer Advertising, DTCA, Tax Law, Excessive Prescribing

38.

How Medicare Could Get Better Prices On Prescription Drugs

Health Affairs, Vol. 28, No. 5, 2009
Number of pages: 10 Posted: 22 Nov 2009 Last Revised: 16 Apr 2013
Kevin Outterson and Aaron S. Kesselheim
Boston University School of Law and Brigham and Women's Hospital/Harvard Medical School
Downloads 42 (318,716)
Citation 2

Abstract:

Drug costs, Medicare Part D, therapeutic substitution, drug importation

39.

All Pain, No GAIN: Need for Prudent Antimicrobial Use Provisions to Complement the GAIN Act

APUA Clinical Newsletter, Vol. 30, No. 1, p. 13 (2012), Boston Univ. School of Law, Public Law Research Paper No. 12-29, Boston Univ. School of Law, Law and Economics Research Paper No. 12-29
Number of pages: 4 Posted: 01 Jun 2012
Kevin Outterson
Boston University School of Law
Downloads 38 (327,476)

Abstract:

new antibiotics, Prescription Drug User Fee Act V, PDUFA V, The Generating Antibiotic Incentives Now Act, GAIN Act, antimicrobial resistance, antimicrobial stewardship incentives

40.

Germ Shed Management in the United States

ANTIBIOTIC POLITICES: CONTROLLING HOSPITAL-ASSOCIATED INFECTION, Ian M. Gould, Jos van der Meer, eds., Springer, 2011, Boston Univ. School of Law Working Paper No. 11-19
Number of pages: 23 Posted: 20 May 2011
Kevin Outterson and Olga Yevtukhova
Boston University School of Law and Boston University - School of Public Health
Downloads 37 (345,765)
Citation 1

Abstract:

antibiotic, infection, hospital, fraud and abuse

41.

Business Model Options for Antibiotics: Learning from Other Industries

Chatham House, The Royal Institute of International Affairs (London) and the Big Innovation Centre (London), 2015, Boston Univ. School of Law, Public Law Research Paper No. 15-05
Number of pages: 43 Posted: 25 Feb 2015
Ella Jaczynska, Kevin Outterson and Jorge Mestre-Ferrandiz
GlaxoSmithKline, Boston University School of Law and Office of Health Economics
Downloads 34 (278,775)

Abstract:

antibiotics, innovation, new drugs, resistance

42.

Market-Based Licensing for HPV Vaccines in Developing Countries

Health Affairs, Vol. 27, No. 1, 2008
Number of pages: 14 Posted: 22 Nov 2009 Last Revised: 11 Feb 2014
Kevin Outterson and Aaron S. Kesselheim
Boston University School of Law and Brigham and Women's Hospital/Harvard Medical School
Downloads 23 (415,434)
Citation 1

Abstract:

Compulsory license, HPV vaccine, generic open license, access to vaccines

43.

Brief Amici Curiae of Prescription Policy Choices, Professors of Law, and Professors of Health Policy in Support of Petitioners on the Minimum Coverage Provision in Department of Health & Human Services v. State of Florida

Boston Univ. School of Law, Public Law Research Paper No. 12-26, Boston Univ. School of Law, Law and Economics Research Paper No. 12-26
Number of pages: 53 Posted: 01 Jun 2012
Boston University - School of Law, Boston University School of Law, Office of Chief Counsel, Food and Drug Administration, affiliation not provided to SSRN, Boston University School of Law and affiliation not provided to SSRN
Downloads 21 (410,709)

Abstract:

Article I, individual mandate, Necessary and Proper Clause, Commerce Clause

44.

Testimony of Kevin Outterson (Boston University School of Law) to the House Energy and Commerce Committee, September 19, 2014

Boston Univ. School of Law, Public Law Research Paper No. 14-51, Boston Univ. School of Law, Law and Economics Research Paper No. 14-51
Number of pages: 19 Posted: 25 Sep 2014
Kevin Outterson
Boston University School of Law
Downloads 20 (384,549)

Abstract:

antimicrobial resistance, bacterial diseases, health system, incentives to produce new antibiotics

45.

What Will It Take to Address the Global Threat of Antibiotic Resistance?

Journal of Law, Medicine and Ethics, Summer 2015, Boston Univ. School of Law, Public Law Research Paper No. 15-31
Number of pages: 7 Posted: 09 Aug 2015 Last Revised: 15 Aug 2015
Steven J. Hoffman and Kevin Outterson
University of Ottawa - Common Law Section and Boston University School of Law
Downloads 11 (274,377)

Abstract:

antibiotic resistance, innovation, prize, delinkage

46.

Repairing the Broken Market for Antibiotic Innovation

Health Affairs, Vol. 34, No. 2, 2015, Boston Univ. School of Law, Law and Economics Research Paper No. 15-32
Number of pages: 11 Posted: 09 Aug 2015 Last Revised: 21 Aug 2015
Boston University School of Law, George Washington University, Brookings Institution - Engelberg Center for Health Care Reform and Brookings Institution
Downloads 10 (315,864)

Abstract:

antibiotic resistance, innovation, prize, delinkage

47.

Analytical Framework for Examining the Value of Antibacterial Products

Submitted to the U.S. Department of Health and Human Services, April 2014, Boston Univ. School of Law, Public Law Research Paper No. 14-25
Number of pages: 107 Posted: 22 Sep 2015 Last Revised: 22 Oct 2015
Eastern Research Group, Inc., Eastern Research Group, Inc., Eastern Research Group, Inc., Eastern Research Group, Inc., Eastern Research Group, Inc., Eastern Research Group, Inc. and Boston University School of Law
Downloads 6 (302,513)

Abstract:

antibacterial products, innovation, antibacterial resistance, product development, delinkage

48.

Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules?

The New England Journal of Medicine 371;1 July 3, 2014, Boston Univ. School of Law, Public Law Research Paper No. 14-77
Number of pages: 4 Posted: 09 Aug 2015 Last Revised: 15 Aug 2015
Kevin Outterson
Boston University School of Law
Downloads 5 (482,202)

Abstract:

clinical trial transparency, biomedical science

49.

The Drug Quality and Security Act - Mind the Gaps

The New England Journal of Medicine 370;97-99, January 9, 2014, Boston Univ. School of Law, Public Law Research Paper No. 13-61
Number of pages: 4 Posted: 12 Aug 2015 Last Revised: 15 Aug 2015
Kevin Outterson
Boston University School of Law
Downloads 4 (430,559)

Abstract:

Drug Quality and Security Act, NECC, regulation, compounded medicines

50.

Fighting Antibiotic Resistance: Marrying New Financial Incentives to Meeting Public Health Goals

Health Affairs, Vol. 29, No. 9, September 2010 , Boston Univ. School of Law Working Paper No. 10-40
Number of pages: 8 Posted: 16 Nov 2010 Last Revised: 08 Aug 2015
Kevin Outterson and Aaron S. Kesselheim
Boston University School of Law and Brigham and Women's Hospital/Harvard Medical School
Downloads 1 (456,519)
Citation 1

Abstract:

antibiotic resistance, antibiotics, drug development, patenting of antibiotics

51.

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Boston Univ. School of Law, Public Law Research Paper No. 16-25
Number of pages: 7 Posted: 15 Jun 2016 Last Revised: 12 Jul 2016
Boston University School of Law, Norwegian Institute of Public Health, Centre on Global Health Security - Chatham House, Johns Hopkins University - School of Hygiene and Public Health, McGill University and Norwegian Knowledge Center for the Health Services
Downloads 0 (446,204)

Abstract:

antibiotic, delinkage, resistance

52.

Funding Antibiotic Innovation with Vouchers: Recommendations on How to Strengthen a Flawed Incentive Policy

Health Affairs, Vol. 35, No. 5, 2016, Boston Univ. School of Law, Public Law Research Paper No. 16-15
Number of pages: 8 Posted: 04 May 2016
Kevin Outterson and Anthony McDonnell
Boston University School of Law and University of South Australia
Downloads 0 (435,726)

Abstract:

antibiotic resistance, patents, intellectual property, health law, pandemics

53.

International Cooperation to Improve Access to and Sustain Effectiveness of Antimicrobials

The Lancet, Volume 387, No. 10015, pp. 296-307, 2016, Boston Univ. School of Law, Public Law Research Paper No. 16-16, Ottawa Faculty of Law Working Paper No. 2016-22
Number of pages: 13 Posted: 04 May 2016 Last Revised: 10 Jun 2016
University of Oslo, Boston University School of Law, University of Ottawa - Common Law Section, Apollo Hospital, St George's Hospital Medical School, Royal Free Hospital, London School of Hygiene and Tropical Medicine, ReAct - Action on Antibiotic Resistance, University of Pennsylvania - Department of Medicine, Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Georgetown University Law Center, McGill University, Yale University, Law School, Students, Independent, Chatham House - Centre on Global Health Security, World Health Organization - Communicable Diseases, McGill University, Imperial College London, The Center for Disease Dynamics, Economics & Policy (CDDEP), University of Cape Town (UCT) and Norwegian Knowledge Center for the Health Services
Downloads 0 (401,424)

Abstract:

antibiotic resistance, patents, intellectual property, health law, pandemics

54.

Antibiotic Reimbursement in a Model Delinked from Sales: A Benchmark-Based Worldwide Approach

Lancet Infect Dis 2016; 16: 500-505, Boston Univ. School of Law, Public Law Research Paper No. 16-14
Number of pages: 6 Posted: 27 Mar 2016 Last Revised: 04 May 2016
John H Rex and Kevin Outterson
Independent and Boston University School of Law
Downloads 0 (415,434)

Abstract:

antibiotic resistance, patents, intellectual property, health law, pandemics